The deadline for submission an abstract is passed.

Abstract handling will be carried out by: FIP

Office opening hours: Monday to Friday 09:00 – 17:00 CET
E-mail: abstracts@fip.org

Submiting an abstract

Abstracts must be submitted using the online abstract form. Paper, faxed or emailed submissions will be rejected.

The presenting author is invited to indicate on the form, his or her preference for oral or poster presentation. However, the final decision is that of the reviewer and programme committee and will be influenced by the quality and suitability of the abstract and logistics such as presentation space and time.

Tip If you have prepared your abstract in Word, check that no changes are introduced when you copy and paste into the online submission form.

Most frequent reasons for abstract rejection
  
– Not properly written/ not understandable
– No new information provided
– Previously published
– Promotional in nature
– Duplicate of another abstract

The review process

After the submission of your abstract, a uniform review process will take place. The goal is not to limit the number of presentations or posters but to ensure that all abstracts published meet minimum professional standards and reflect good work.

Reviewers ask the following five basic questions:

  1. Does the work address a significant or important issue?
  2. Is the work new or has it been published already?
  3. Do the methods/approach enable the question asked at the start of the project to be answered rigorously?
  4. Have the data/findings been interpreted appropriately?
  5. Are the contents of the abstract clear and intelligible?

The outcome of the review will be emailed to the main author at the latest by 16 May 2022.

Note, however, that any accepted abstracts will be cancelled if the presenting author has not registered and paid the registration fee for the congress by 15 June 2022. This is the date by which the FIP congress programme materials must be finalised and so authors whose attendance cannot be confirmed by registration will not be scheduled. Their abstracts cannot be presented and will not be published.

© Copyright 2022 International Pharmaceutical Federation